Aspects to Consider for a More Useful, Discriminative Predictive Tool for CAP Mortality in T2DM [Letter]
Dan Geltser Imperial College London, School of Medicine, London, UKCorrespondence: Dan Geltser Email dg1116@ic.ac.uk I read with great interest the paper by Ma et al1 which explored the sensitivity and specificity of using CURB-65 and the PSI scoring systems to predict mortality in type 2 diabetes m...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/430191421c9f4a0593c78b2e95029d37 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Dan Geltser Imperial College London, School of Medicine, London, UKCorrespondence: Dan Geltser Email dg1116@ic.ac.uk
I read with great interest the paper by Ma et al1 which explored the sensitivity and specificity of using CURB-65 and the PSI scoring systems to predict mortality in type 2 diabetes mellitus (T2DM) patients with community-acquired pneumonia (CAP). The study importantly identified the need for a more specific prediction model in T2DM cohorts. CAP accompanied with T2DM commonly presents in both primary care and the ED and as a 5th-year medical student I would like to highlight other factors which should be discussed when considering the conclusion and aid the development of a more useful, discriminative tool for the diagnosis and prognosis of CAP in T2DM.
View the original paper by Ma and colleagues |
|---|